Drug Insight: small-molecule inhibitors of protein kinases in the treatment of thyroid cancer-Reference-Cited by-同舟云学术

Drug Insight: small-molecule inhibitors of protein kinases in the treatment of thyroid cancer

Published:2006-01 Issue:1 Volume:2 Page:42-52
ISSN:1745-8366
Container-title:Nature Clinical Practice Endocrinology & Metabolism
language:en
Short-container-title:Nat Rev Endocrinol

Author:

Santoro Massimo,Carlomagno Francesca

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.nature.com/articles/ncpendmet0073.pdf

Reference73 articles.

1. DeLellis RA and Williams ED (2004) Thyroid and parathyroid tumors. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs, 51–56 (Eds DeLellis RA et al.) Geneva: WHO Press

2. Sherman SI (2003) Thyroid carcinoma. Lancet 361: 501–511

3. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306

4. Fagin JA (2004) How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol 183: 249–256

5. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12: 245–262

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects;The Journal of Clinical Endocrinology & Metabolism;2022-06-01

2. Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response;Endocrine-Related Cancer;2020-02

3. RET Tyrosine Kinase Receptor;Encyclopedia of Signaling Molecules;2018

4. Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade;F1000Research;2016-08-23

5. Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade;F1000Research;2016-05-26